semaglutide for pcos weight loss Rising use of GLP-1 medications among women with PCOS Weight Loss: Semaglutide &

Subcutaneous Semaglutide during Breastfeeding: Infant Safety Regarding Drug Transfer into Human Milk

Treatment of pre-existing obesity: animals with genetic mutations (ob/ob or db/db mice) causing obesity or high-fat diet-induced obesity at baseline

However, certain physiological changes associated with GLP-1 receptor agonistsincluding reduced fluid intake, weight loss, and metabolic shiftsmay theoretically increase kidney stone risk in predisposed individuals

In addition to enhancing lipid metabolism, the combination GIP-GLP1 may improve weight parameters by acting on receptors located in the central nervous system (CNS)

While acknowledging these difficulties may paint a concerning picture, it highlights the importance of treatments such as Atomoxetine in managing these debilitating symptoms and enhancing overall quality of life

PMID: 10 ElyEWBrownLMFinebergHV